Medicine meets therapy — rapid-acting relief for treatment-resistant depression, with integration.
At a glance
What it is
Ketamine at low doses is paired with therapy to treat depression, PTSD, and suicidality.
Why explore it
KAP may lift mood when antidepressants have failed, and esketamine is FDA-approved for that.
How it’s experienced
A doctor administers ketamine while a therapist guides you through preparation and integration.
Evidence context
Early results look promising for depression and PTSD, though long-term research is still ongoing.
See the evidence snapshotSafety
Medical supervision is essential since ketamine carries risks of dissociation and dependency.
See staying safeHistory & Origin
Ketamine-Assisted Psychotherapy (KAP) combines the rapid-acting antidepressant effects of sub-anaesthetic ketamine with structured psychotherapeutic processing to address treatment-resistant mental health conditions.
Ketamine has been used as an anaesthetic since 1970. Its rapid antidepressant properties were first demonstrated by Berman et al. (2000) at Yale University. Johnson & Johnson developed esketamine (Spravato), which received FDA approval in 2019 for treatment-resistant depression. Simultaneously, off-label use of generic racemic ketamine grew rapidly in US ketamine clinics from the mid-2010s. KAP emerged from clinicians who recognised that ketamine''s therapeutic potential was enhanced when combined with psychotherapy rather than administered as a standalone infusion. The Ketamine Research Foundation, MAPS, and various training programmes developed structured KAP protocols. By the mid-2020s, hundreds of KAP clinics operated in the US, with growing presence in Australia, UK, and other jurisdictions. The practice sits at the intersection of psychiatry, psychedelic-assisted therapy, and psychotherapy, with ongoing debate about optimal protocols and practitioner qualifications.
Mechanism
Ketamine-Assisted Psychotherapy is generally framed as a guided process for attention, reflection, learning, and emotional integration. Depending on the method, a practitioner may use conversation, imagery, structured exercises, body awareness, or therapeutic techniques to help the person explore patterns and choices. It should not be presented as a standalone solution or a substitute for urgent care, but it may support self-understanding when practiced within an appropriate scope. Ketamine-Assisted Psychotherapy is best understood through the way practitioners describe its session process, goals, and context.
Your first visit
A typical session outline to help you feel prepared
A ketamine-assisted psychotherapy session blends medicine, music, and therapeutic presence to open a window into your inner world and support meaningful personal insight.
Before any medicine is involved, you meet with your therapist to set intentions, review what to expect, and discuss any concerns. This builds the trust and groundwork that shapes your experience.
On session day you arrive at a calm, comfortable space designed to feel safe and welcoming. You may be offered water, a blanket, and time to settle before anything begins.
Your therapist and a medical provider briefly review how you're feeling physically and emotionally that day, confirm your intentions, and answer any last-minute questions before administering the ketamine.
Ketamine is given in a clinical setting, often as a lozenge held under the tongue or via an IV, depending on the practice. The dose is carefully calibrated for a therapeutic, not overwhelming, experience.
You rest on a comfortable surface with eyeshades on and curated music playing as ketamine gently shifts your awareness into a dreamlike, introspective state lasting 45 to 90 minutes. Your therapist st
As the medicine effect softens, you slowly return to ordinary awareness. Your therapist may offer quiet, grounding presence or light conversation to help you re-orient at your own pace.
Once you feel stable, you and your therapist spend time gently exploring what images, feelings, or insights arose during the journey, capturing them while they are still fresh.
Before you leave, you schedule follow-up integration sessions where you will work with your therapist to weave your experience into everyday life. A trusted person drives you home, as driving that day is not permitted.
The Evidence
What research currently shows about Ketamine-Assisted Psychotherapy, where the evidence is strong, and where gaps remain.
Strong drug data, limited combined-therapy trials
Ketamine alone has solid clinical evidence for rapid antidepressant effects, including FDA-approved esketamine. The specific combination with structured psychotherapy is promising but supported by fewer rigorous trials, making KAP an emerging rather than established practice.
Meta-analyses consistently indicate ketamine's rapid antidepressant effects — though this applies to ketamine alone, not KAP as a combined modality. Esketamine (Spravato) holds FDA approval for treatment-resistant depression based on Phase 3 trials. Research specifically examining KAP — ketamine combined with structured psychotherapy — is limited, with early clinical reports emerging around 2019. Evidence for psychotherapy extending durability is promising but not yet conclusive.
Clinicians propose that ketamine creates a short neurobiological window of enhanced plasticity — through NMDA antagonism and increased BDNF — during which psychotherapeutic work may be more effective. The integration phase, where experiences from the medicine session are processed, is considered central to producing durable outcomes beyond ketamine's transient pharmacological window of days to weeks.
KAP is not an alternative to psychiatry; it is used alongside or within psychiatric care for people who have not responded to standard approaches. It requires medical oversight, appropriate prescribing, and qualified psychotherapeutic support. Unlike most complementary modalities, KAP involves a dissociative medicine session — a pharmacologically active state that distinguishes it from conventional therapy and places it firmly in the complementary rather than alternative tier.
Ketamine can cause dissociation, nausea, elevated blood pressure, and dizziness during sessions. Psychological distress is managed through therapist presence and structured preparation. Ketamine has abuse potential, requiring responsible prescribing and monitoring. At-home or telehealth-only administration raises additional safety concerns specific to this modality. Regulatory status varies by country — ketamine is a controlled substance in most jurisdictions.
Practitioners should hold appropriate medical credentials for ketamine prescribing and administration, alongside recognised psychotherapy qualifications. Training in KAP-specific protocols is strongly advisable. The rapid growth of ketamine clinics has outpaced regulatory frameworks in some regions, making it important to verify practitioner credentials and clinical setting standards before engaging with any provider.
Most ketamine trials did not include structured psychotherapy, making it difficult to isolate the contribution of the combined approach. Long-term outcomes, optimal dosing, and ideal psychotherapy modalities remain under investigation. The field lacks standardised protocols. Seekers considering KAP should discuss realistic expectations with a qualified clinician and not rely on inflated outcome claims circulating in popular media.
Safety first
General guidance to help you decide whether this approach is appropriate for you. This is informational only and not a substitute for medical, psychological, or professional advice.
Some situations call for extra care or a different approach. Share any conditions, injuries, or sensitivities with your practitioner before your first session.
If you are pregnant, managing a health condition, recovering from injury or surgery, or taking medication, consult a qualified healthcare professional first.
Look for clear boundaries, transparent pricing, and practitioners who avoid fear-based claims or pressure to book frequent sessions.
Mild, short-lived effects such as tenderness, tiredness, or temporary soreness can occur. Rest, hydrate, and tell your practitioner how you respond.
For you?
A simple, human way to weigh it up. This is general guidance, not personal medical advice — a qualified practitioner can advise on your situation.
Gyfts is a discovery platform, not a medical provider. Nothing here diagnoses, treats or replaces professional care. In an emergency, contact your local emergency number.
Featured
These practitioners have chosen to be featured on Gyfts.
In their words
FAQ
Ketamine is a legal, FDA-approved medication prescribed off-label for depression. Esketamine (Spravato) has specific FDA approval for treatment-resistant depression. KAP is legal when ketamine is prescribed by a licensed physician and administered in an appropriate clinical setting.
Ketamine infusion clinics typically administer IV ketamine for its pharmacological antidepressant effect without concurrent psychotherapy. KAP adds structured preparation and integration therapy, proposing that the combination produces more durable outcomes.
When administered in a supervised clinical setting with proper medical monitoring, KAP has an established safety profile. Side effects include dissociation, nausea, elevated blood pressure, and dizziness. At-home ketamine prescribing raises additional safety concerns.
Ketamine''s antidepressant effects can begin within hours — much faster than conventional antidepressants (which take 4–6 weeks). However, these effects tend to be transient (days to weeks) without repeated administration or psychotherapy integration.
Esketamine (Spravato) may be covered by some insurance plans for treatment-resistant depression. Generic ketamine used off-label and the psychotherapy component are typically not covered. Costs vary significantly by clinic and protocol.
At sub-anaesthetic doses, ketamine typically produces a dreamlike, dissociative state. Patients often describe floating sensations, vivid imagery, emotional insights, and altered perception of time and space. The experience is generally gentler than full anaesthesia.
References
Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.
Full citations are maintained by the Gyfts editorial team and reviewed periodically.
Keep exploring
Browse verified practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.
